World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
83
Citations
24754
World Ranking
1445
National Ranking
11

Haiming Wei publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Haiming Wei sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 296 publications — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Haiming Wei D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Haiming Wei sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 83 D-Index — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Haiming Wei is affiliated with the University of Science and Technology of China in China. Their research spans primarily the fields of Medicine and Immunology and Microbiology, with significant contributions across multiple subfields including Immunology, Infectious Diseases, Oncology, Molecular Biology, and Epidemiology.

Their work has been published extensively, with frequent appearances in several scientific journals. Notable venues include:

  • Frontiers in Immunology (10 publications)
  • Blood (5 publications)
  • Proceedings of the National Academy of Sciences (4 publications)
  • Nature Communications (3 publications)
  • Cellular and Molecular Immunology (3 publications)

Haiming Wei's main research topics include:

  • Immune Cell Function and Interaction
  • COVID-19 Clinical Research Studies
  • Reproductive System and Pregnancy
  • Long-Term Effects of COVID-19
  • Immune cells in cancer
  • Immunotherapy and Immune Responses
  • SARS-CoV-2 and COVID-19 Research

Several recent papers illustrate the focus of Wei's research. These include:

  • "Effective treatment of severe COVID-19 patients with tocilizumab," published in 2020 in Proceedings of the National Academy of Sciences
  • "Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients," published in 2020 in National Science Review
  • "Why tocilizumab could be an effective treatment for severe COVID-19?" published in 2020 in Journal of Translational Medicine
  • "Aberrant pathogenic GM-CSF+T cells and inflammatory CD14+CD16+monocytes in severe pulmonary syndrome patients of a new coronavirus," published in 2020 in bioRxiv (Cold Spring Harbor Laboratory)
  • "Role of Decidual Natural Killer Cells in Human Pregnancy and Related Pregnancy Complications," published in 2021 in Frontiers in Immunology

Haiming Wei has collaborated frequently with a number of coauthors, including:

  • Binqing Fu (48 joint publications)
  • Zhigang Tian (36 joint publications)
  • Yonggang Zhou (35 joint publications)
  • Rui Sun (32 joint publications)
  • Xiaohu Zheng (27 joint publications)

Best Publications

  • Effective treatment of severe COVID-19 patients with tocilizumab.

    Xiaoling Xu;Mingfeng Han;Tiantian Li;Wei Sun

  • Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients

    Yonggang Zhou;Binqing Fu;Xiaohu Zheng;Dongsheng Wang

  • Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity.

    Qing Zhang;Jiacheng Bi;Xiaodong Zheng;Yongyan Chen

  • Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell–dependent inflammation

    Jian Wang;Fengqi Li;Haiming Wei;Zhe-Xiong Lian

  • Liver-resident NK cells confer adaptive immunity in skin-contact inflammation.

    Hui Peng;Xiaojun Jiang;Yonglin Chen;Dorothy K. Sojka

  • Why tocilizumab could be an effective treatment for severe COVID-19?

    Binqing Fu;Xiaoling Xu;Haiming Wei

  • Dysfunction of Natural Killer Cells by FBP1-Induced Inhibition of Glycolysis during Lung Cancer Progression

    Jingjing Cong;Xianwei Wang;Xiaohu Zheng;Dong Wang

  • Impaired natural killer (NK) cell activity in leptin receptor deficient mice: leptin as a critical regulator in NK cell development and activation.

    Zhigang Tian;Rui Sun;Rui Sun;Rui Sun;Haiming Wei;Haiming Wei;Bin Gao

  • Natural Killer Cells Promote Fetal Development through the Secretion of Growth-Promoting Factors

    Binqing Fu;Yonggang Zhou;Xiang Ni;Xianhong Tong

  • Natural Killer Cells Promote Immune Tolerance by Regulating Inflammatory TH17 Cells at the Human Maternal-Fetal Interface

    Binqing Fu;Xian Chang Li;Xian Chang Li;Rui Sun;Xianhong Tong

  • Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance.

    Xiaohu Zheng;Yeben Qian;Binqing Fu;Defeng Jiao

  • High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer.

    Cheng Sun;Jing Xu;Qiang Huang;Mei Huang

  • Human CD96 Correlates to Natural Killer Cell Exhaustion and Predicts the Prognosis of Human Hepatocellular Carcinoma.

    Haoyu Sun;Qiang Huang;Mei Huang;Hao Wen

  • Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus

    Yonggang Zhou;Binqing Fu;Xiaohu Zheng;Dongsheng Wang

  • Developmental and Functional Control of Natural Killer Cells by Cytokines.

    Yang Wu;Zhigang Tian;Haiming Wei

  • Bacterial colonization dampens influenza-mediated acute lung injury via induction of M2 alveolar macrophages

    Jian Wang;Fengqi Li;Rui Sun;Xiang Gao

  • Subsets of human natural killer cells and their regulatory effects.

    Binqing Fu;Zhigang Tian;Haiming Wei

  • Role of Decidual Natural Killer Cells in Human Pregnancy and Related Pregnancy Complications.

    Xiuhong Zhang;Haiming Wei

  • CD11b and CD27 reflect distinct population and functional specialization in human natural killer cells.

    Binqing Fu;Fuyan Wang;Rui Sun;Bin Ling

  • High-mobility group box 1 (HMGB1)-Toll-like receptor (TLR)4-interleukin (IL)-23-IL-17A axis in drug-induced damage-associated lethal hepatitis: Interaction of γδ T cells with macrophages.

    Xuefu Wang;Rui Sun;Haiming Wei;Zhigang Tian

  • TGF-β1 Down-Regulation of NKG2D/DAP10 and 2B4/SAP Expression on Human NK Cells Contributes to HBV Persistence

    Cheng Sun;Binqing Fu;Yufeng Gao;Xiaofeng Liao

  • The roles of innate immune cells in liver injury and regeneration.

    Zhongjun Dong;Haiming Wei;Rui Sun;Zhigang Tian

Frequent Co-Authors

Zhigang Tian
Zhigang Tian University of Science and Technology of China
Rui Sun
Rui Sun University of Science and Technology of China
Xiang Gao
Xiang Gao Nanjing University
Xian Chang Li
Xian Chang Li Cornell University
Bin Gao
Bin Gao National Institutes of Health
Wayne M. Yokoyama
Wayne M. Yokoyama Washington University in St. Louis
Zhe-Xiong Lian
Zhe-Xiong Lian University of Science and Technology of China
Zhong-Qun Tian
Zhong-Qun Tian Xiamen University
Nan Shen
Nan Shen Shanghai Jiao Tong University
Yuan Chen
Yuan Chen University of Sydney

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA offers diverse career opportunities, especially when paired with relevant degrees in healthcare. For those interested in advanced nursing roles, understanding salary expectations is key. Exploring the dnp salary by state can help prospective students make informed decisions about where to study and work.

Nurses aiming to specialize can benefit from advanced training programs. For example, transitioning from a Family Nurse Practitioner to specialized acute care is supported through accredited acnp programs that build on existing experience.

For those looking to accelerate their entry into advanced practice roles, considering the accelerated fnp options can reduce the time needed to become a Family Nurse Practitioner. These programs are designed for efficiency without sacrificing quality.

Additionally, non-nurse students interested in healthcare can pursue a nursing career through 12-month accelerated nursing programs online for non nurses. These intensive programs provide a swift pathway into nursing, which can complement immunology expertise and open multidisciplinary career paths.

Best Scientists Citing Haiming Wei

Trending Scientists

Recently Published Articles